Supplemental material
Future Oncology
Volume 17, 2021 - Issue 31
Clinical Trial Protocol
Neoadjuvant Osimertinib With/Without Chemotherapy Versus Chemotherapy Alone for EGFR-Mutated Resectable Non-Small-Cell Lung Cancer: NeoADAURA
Masahiro Tsuboi1 National Cancer Center Hospital East, Kashiwa, Chiba277-8577, Japan
https://orcid.org/0000-0003-3031-5807View further author information
https://orcid.org/0000-0003-3031-5807View further author information, , Carles Escriu3 The Clatterbridge Cancer Centre, Bebington, Wirral, CH63 4JY, UKhttps://orcid.org/0000-0003-3638-3202View further author information
https://orcid.org/0000-0003-3638-3202View further author information, Collin Blakely4 Department of Medicine, University of California, San Francisco, CA94158-2140, USAhttps://orcid.org/0000-0001-8134-3651View further author information
https://orcid.org/0000-0001-8134-3651View further author information, , , , , & Jamie E Chaft10 Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center & Weill Cornell Medical College, New York, NY10021, USACorrespondence[email protected]
https://orcid.org/0000-0002-5838-9982View further author information
https://orcid.org/0000-0002-5838-9982View further author information show all